Inventurus Knowledge Solutions (IKS), a prominent healthcare technology company, has opened its IPO for subscription, aiming to raise approximately ₹2,497.92 crores. The issue, which includes both a fresh issue and an offer-for-sale of up to 1.87 crore equity shares, will close on December 16, 2024. The IPO is priced in the range of ₹1,265 to ₹1,329 per share.
The IPO has generated significant attention in the market, buoyed by the backing of prominent investor Rekha Jhunjhunwala. As of now, the grey market premium (GMP) for IKS stands at ₹405, indicating a 30.47% premium over the upper price band. This suggests that the stock could list at ₹1,734, up from the upper issue price of ₹1,329, signaling strong investor optimism.
Subscription Trends and Investor Sentiment
The IPO has seen substantial demand across all investor categories. The retail individual investors (RIIs) segment has been subscribed 4.24 times, while non-institutional investors’ category saw 3.13 times subscription. Qualified institutional buyers (QIBs) achieved a subscription rate of 1.89 times, reflecting broad-based interest in the offering.
These positive subscription trends, combined with the strong GMP, suggest that market participants are bullish on IKS’s prospects, expecting the stock to debut with a solid premium.
IPO Structure and Key Details
The Inventurus Knowledge Solutions IPO is being offered at a price band of ₹1,265 to ₹1,329 per share. The allocation for qualified institutional buyers (QIBs) is set at 75%, with 15% reserved for high-net-worth individuals (HNIs) and 10% for retail investors. The shares are expected to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) on December 19, 2024, with allotments finalized by December 17, 2024.
Company Performance and Growth Potential
IKS has shown impressive financial growth, with revenue rising to ₹1,817.93 crores in FY 2024, up from ₹1,031.30 crores in FY 2023. Net profit also grew from ₹305.23 crores in FY 2023 to ₹370.49 crores in FY 2024. This robust expansion positions IKS as a strong player in the healthcare technology sector.
Founded in 2006, IKS specializes in healthcare solutions that streamline administrative tasks for healthcare providers. Its services, including medical documentation management, virtual medical scribing, and clinical support, reduce the administrative burden on healthcare organizations, allowing them to focus more on patient care.
With solid financials and strong market sentiment, Inventurus Knowledge Solutions is set to be a key player in the healthcare services sector, and investors are keenly watching the IPO’s performance.
